Nov 18 (Reuters) - Revvity Inc :
* REVVITY: EFFECTIVE FISCAL 2025, MAJORITY OF APPLIED GENOMICS UNIT TO BE INTEGRATED INTO LIFE SCIENCES SOLUTIONS UNIT
* REVVITY: FROM FISCAL 2025, LIFE SCIENCES REPORTING SEGMENT WILL CONSIST OF LIFE SCIENCES SOLUTIONS & SOFTWARE
* REVVITY: FROM FISCAL 2025, DIAGNOSTICS REPORTING SEGMENT WILL CONSIST OF IMMUNODIAGNOSTICS & REPRODUCTIVE HEALTH
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.